NovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded Products
10 Julho 2023 - 7:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company
developing and commercializing high-quality eyecare, skincare and
wound care products, announces special pricing on Avenova®-branded
products to Amazon prime members during Prime Day 2023, being held
July 11-12.
“Prime Day offers a significant opportunity to increase sales
through this important channel,” said Justin Hall, NovaBay CEO.
“During last year’s Prime Day event, we broke the all-time
single-day Avenova sales record since we began offering our
products on Amazon in June 2019. We anticipate another strong
showing during this year’s event bolstered by our exclusive
promotional pricing.
“Over the past several years we’ve expanded our suite of
best-in-class Avenova products to help those afflicted with chronic
dry eye, which can be a complex disorder to manage,” he added. “It
is our pleasure to reward current Amazon prime customers with
discounts on the Avenova products they routinely use while offering
special pricing on other products that may provide further relief.
We also expect to attract Amazon prime members who are new to
Avenova with the potential of converting them into long-term, loyal
customers for our superior-quality products.”
Throughout the two-day event, NovaBay will offer Prime Exclusive
Discounts that include 20% discounts on Avenova Antimicrobial Lid
& Lash Solution (Avenova Spray), Avenova Spray and Avenova Wipe
Combo and Avenova Lubricating Eye Drops, and a 50% discount on
Avenova Eye Health Support Oral Supplement with MaquiBright®.
During the Lightning Deal on July 11 from 8:05 a.m. to 8:05 p.m.
Pacific time, the Avenova Spray and Avenova Wipe Combo will be
available at a 20% discount. As a follow-up to the event, Amazon
prime members will be offered single-purchase coupons for 20%
discounts on Avenova Lubricating Drops and Avenova Eye Health
Supplements, and an additional 10% discount on the first Subscribe
& Save order for Avenova Spray and Avenova Spray and Wipe Combo
from July 13-17.
NovaBay’s Avenova Spray is the No. 1 physician-recommended
antimicrobial lid and lash cleanser. All Avenova products are
highly rated on Amazon.com, with Avenova Spray receiving 4.5 out of
5 stars from nearly 13,000 reviews, including 86% of ratings at 4
stars or above.
About NovaBay Pharmaceuticals, Inc.:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically
created and clinically proven eyecare and skincare products.
NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash
Solution, is often prescribed by eyecare professionals for
blepharitis and dry-eye disease and is also available directly to
eyecare consumers through online distribution channels such as
Amazon. DERMAdoctor® offers more than 30 dermatologist-developed
skincare products through the DERMAdoctor website, well-known
traditional and digital beauty retailers, and international
distributors. NovaBay also manufactures and sells effective, yet
gentle and non-irritating wound care products. The PhaseOne® brand
is distributed through commercial partners in the U.S. for
professional use only, and the NeutroPhase® brand is distributed in
China by Pioneer Pharma (Hong Kong) Company Ltd.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in
this press release may be forward looking within the meaning of the
“safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995, including statements about the commercial
progress and future financial performance of NovaBay
Pharmaceuticals, Inc. This release contains forward-looking
statements that are based upon management’s current expectations,
assumptions, estimates, projections and beliefs. These statements
include, but are not limited to, statements regarding our
anticipated sales on Prime Day, marketing strategies, current
partnerships, and any future revenue that may result from such
partnerships and related marketing strategies, as well as generally
the Company’s expected future financial results. These statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results or achievements to be materially
different and adverse from those expressed in or implied by the
forward-looking statements. Factors that might cause or contribute
to such differences include, but are not limited to, risks and
uncertainties relating to the size of the potential market for our
products, the possibility that the available market for the
Company’s products will not be as large as expected, the Company’s
products will not be able to penetrate one or more targeted
markets, and revenues will not be sufficient to meet the Company’s
cash needs. Other risks relating to NovaBay’s business, including
risks that could cause results to differ materially from those
projected in the forward-looking statements in this press release,
are detailed in NovaBay’s latest Form 10-Q/K filings and
Registration Statement on Form S-1 filing with the Securities and
Exchange Commission, especially under the heading “Risk Factors.”
The forward-looking statements in this release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on
Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s
Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230710673264/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024